Drug Shortage Report for AURO-SITAGLIPTIN

Last updated on 2025-01-31 History
Report ID 242981
Drug Identification Number 02529874
Brand name AURO-SITAGLIPTIN
Common or Proper name Auro-Sitagliptin
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) SITAGLIPTIN
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 500
ATC code A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-11-14
Estimated end date 2025-01-30
Actual end date 2025-01-30
Shortage status Resolved
Updated date 2025-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-01-31 English Compare
v7 2025-01-30 French Compare
v6 2025-01-30 English Compare
v5 2025-01-03 French Compare
v4 2025-01-03 English Compare
v3 2024-11-15 English Compare
v2 2024-11-14 French Compare
v1 2024-11-14 English Compare

Showing 1 to 8 of 8